ACTION AND DESCRIPTION
Indicated in the restoration and improvement of the stability of the lagrimal film in the dry eye syndrome, after refractive surgery, for eye relief in cases of redness, fatigue and discomfort of the eye or eye mucosa.
CE marking
Notified Agency No. 1936
Class IIb
Sterilly
COMPOSITION
Aqueous solution of sodium hyaluronate reticulate polymer (of which the sodium hyaluronate reticulate polymer is 0.4%), trometamol, hydrochloric acid 2N, sodium chloride, injectable water.
CONSERVATION AND DACITY
Keep between 2o and 30o C in a dry place, away from heat and direct sun exposure.
30 joints: The solution should be used within 12 hours after the opening of the container.
10 ml: Once the container is opened, you can use it for the next 90 days.
EMPLEMENTATION MODEL
Wrap 30 joints: Separate a joint container from the strip and open it by turning and then lifting the closure cap. Install 2 drops in each eye by slightly pressing the container. After use immediately close the joint packaging.
Packaging 10 ml: Wash your hands carefully. Break the security precinct before the first administration. Remove the protective cap and press slightly to instill 2 drops in each eye, unless your doctor says otherwise. After use, close the container.
Project co-financed by the European Social Fund Asturias 2014/2020, within the Consolidation operation Ticket Empresarial 2016